BB3008

· Broadenbio Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BB3008, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of BB3008 in Participants With Advanced Solid Tumors [Phase 1]